Patents by Inventor Marc Peters-Golden

Marc Peters-Golden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VESICLE-ENCAPSULATED SOCS
    Publication number: 20210093565
    Abstract: Provided herein are synthetic vesicles carrying a payload of one or more suppressors of cytokine signaling (SOCS) proteins. In particular, liposomes encapsulating SOCS1 and/or SOCS3, and methods of delivery and use for the treatment of lung disease and conditions, are provided.
    Type: Application
    Filed: January 19, 2017
    Publication date: April 1, 2021
    Inventors: Marc Peters-Golden, James J. Moon
  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    Patent number: 7696148
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: April 13, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Marc Peters-Golden, Theodore Standiford
  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    Publication number: 20050267211
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Application
    Filed: January 19, 2005
    Publication date: December 1, 2005
    Inventors: Marc Peters-Golden, Theodore Standiford
  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    Patent number: 5909734
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Grant
    Filed: December 3, 1996
    Date of Patent: June 8, 1999
    Assignee: Regents of the University of Michigan
    Inventors: Marc Peters-Golden, Theodore Standiford